ESCRS Preview

Article

OTEurope reveals highlights from each day of the ESCRS Congress with the help of three EAB members.

XXXI Congress of the ESCRS

5–9 October 2013, RAI, Amsterdam, The Netherlands

This year's major European event is nearing and the excitement of what will be revealed at the show is peaking once more. The XXXI event will be taking place in the canal ensued Amsterdam in The Netherlands and yet again expectant attendees and exhibitors will have much to look forward to in the packed out programme.

We hope you will find this a useful resource for your event and do also check out the ESCRS Showcase section, directly following this preview feature, for a brief overview of some exciting products that will be on the exhibition floor between 5–8 October.

Friday 4 October

ESCRS Glaucoma Day - 8.30 am–5.30 pm

Once again, the ESCRS will be immediately preceded by the ever popular ESCRS Glaucoma Day. Organized by the European Glaucoma Society (EGS), this year's programme will feature five sessions, covering four main topic areas - Glaucoma Burden, A Challenge To The IOP Concept, Medical Treatment and Surgery in Glaucoma. As with previous year's presentations will be made by key opinion leaders in the field of glaucoma and it is certain the day will not disappoint those attending.

This year, OTEurope's highlights include: Dr Augusto Azuara Blanco's discussion on 'The burden of glaucoma on patients and society: direct and indirect costs', Dr Luciano Quaranta's talk titled, 'How many IOP measurements do we need to make clinical decisions?', Dr Jean-Philippe Nordmann's presentation on 'Quality of generic drugs: equivalent to originals?', Dr Tarek Shaarawy's talk highlighting 'Minimally invasive glaucoma devices: what is the evidence?', and Dr John Thygesen's discussion on "The prevalence of angle closure in Europe'.

The meeting has been awarded 6 CME credits and potential attendees will need to register separately for this meeting. Registration will cost €150 plus VAT.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.